Nasdaq

PTC Therapeutics Launches PTC PINPOINT - A Genetic Testing Program for Individuals Suspected of Having Neurotransmitter Disorders

SOUTH PLAINFIELD, N.J., Sept. 9, 2020 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today introduced a new program that provides genetic testing and counseling for people who may have a ...
MedCity News

Novartis Tries Again in Huntington’s, Putting Up $1B to Partner on a PTC Therapeutics Drug

Nearly six months ago, PTC Therapeutics reported positive interim data for a drug in mid-stage development for Huntington’s disease, an inherited neurological disorder with limited treatment options ...
Nasdaq

PTC Therapeutics Launches A No-Cost Testing Program to Drive AADC Deficiency Patient Identification

SOUTH PLAINFIELD, N.J., Nov. 18, 2019 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced the launch of a no-cost testing program for aromatic L-amino acid decarboxylase (AADC) ...
The Trentonian

PTC Therapeutics Launches the PTC Pinpoint DirectTM Program for Patient-Initiated Genetic Testing

SOUTH PLAINFIELD, N.J., April 14, 2021 /PRNewswire/ — PTC Therapeutics, Inc. (NASDAQ: PTCT) today introduced a new no-charge, patient-initiated testing program in the United States for individuals who ...
Railway Age

Herzog, W&LE complete PTC testing

Wheeling & Lake Erie and Herzog completed brake testing and preparations for Positive Train Control functionality in revenue service by the end of 2018. Herzog, based in Brewster, Ohio, said it ...